Premium
Fatal tracheal aspergillosis during rituximab combined chemotherapy for diffuse large B‐cell lymphoma that developed after lung transplantation
Author(s) -
Kawamoto K.,
Shibasaki Y.,
Sato S.,
Nemoto H.,
Takizawa J.,
Narita M.,
Tsuchida M.,
Sone H.,
Masuko M.
Publication year - 2015
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.12458
Subject(s) - medicine , rituximab , lymphoma , aspergillosis , chemotherapy , bronchoscopy , diffuse large b cell lymphoma , lung , transplantation , radiology , pathology , surgery , immunology
Invasive tracheal aspergillosis ( ITA ) is an infection that is unique to patients who have undergone lung transplantation ( LT ). Although the activity of this disease often appears on imaging, we encountered a case of ITA that became exacerbated, despite few computed tomography ( CT ) findings, during rituximab combined chemotherapy for diffuse large B‐cell lymphoma. ITA developed during immunosuppressive therapy after LT . Because CT findings may show false‐negative results, bronchoscopy is recommended for such cases.